Spectrum Pharmaceuticals, Inc. - General Releases
Spectrum Pharmaceuticals, Inc. - General Releases
Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies Global Healthcare Conference in New York City on June 3rd
Posted: May 30, 2014, 11:00 am
Spectrum Pharmaceuticals Completes Enrollment in Phase 2 Trial of SPI-2012 - A Novel Long-Acting Granulocyte Colony Stimulating Factor (GCSF) to Treat Chemotherapy-induced Neutropenia
Posted: May 28, 2014, 11:00 am
Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas on May 13th
Posted: May 9, 2014, 11:00 am
Spectrum Pharmaceuticals Reports Financial Results for First Quarter 2014
Posted: May 8, 2014, 8:00 pm
Spectrum Pharmaceuticals Announces First Quarter 2014 Financial Results Teleconference and Webcast
Posted: May 1, 2014, 11:00 am
Spectrum Pharmaceuticals' Pivotal Trial of Captisol-Enabled™ (Propylene Glycol-Free) Melphalan Meets Primary Endpoint
Posted: April 23, 2014, 11:00 am
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
Posted: April 21, 2014, 11:00 am
Spectrum Pharmaceuticals to Present Corporate Update at the 26th Annual ROTH Conference in Laguna Niguel on March 11th
Posted: March 7, 2014, 12:00 pm
Spectrum Pharmaceuticals Reports Fourth and Full Year 2013 Financial Results
Posted: March 6, 2014, 9:00 pm
Spectrum Pharmaceuticals Announces Fourth Quarter 2013 Financial Results Teleconference and Webcast
Posted: February 27, 2014, 9:05 pm